During the past decade, Universitätshautklinik Münster conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätshautklinik Münster" #1 sponsor was "Charite University, Berlin, Germany" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored, "RHEACELL GmbH & Co. KG" with 2 trials sponsored and "AB Science" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätshautklinik Münster" #1 collaborator was "FGK Clinical Research GmbH" with 2 trials as a collaborator, "Ticeba GmbH" with 2 trials as a collaborator, "Granzer Regulatory Consulting & Services" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "Proinnovera GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Universitätshautklinik Münster" are "Atopic Dermatitis" (2 trials), "Skin Ulcer Venous Stasis Chronic" (2 trials), "Basal Cell Carcinoma" (1 trials), "Cholinergic Urticaria" (1 trials) and "Chronic Prurigo" (1 trials). Many other conditions were trialed in "Universitätshautklinik Münster" in a lesser frequency.

Most popular intervention types in "Universitätshautklinik Münster" are "Drug" (13 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Vehicle" (2 trials), "allo-APZ2-CVU" (2 trials), "ASN002" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätshautklinik Münster" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Universitätshautklinik Münster". 1 are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Universitätshautklinik Münster, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätshautklinik Münster, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".